Cargando…
Granisetron vs ondansetron: is it a question of duration of 5-HT(3) receptor blockade?
British Journal of Cancer (2002) 86, 1662–1663. DOI: 10.1038/sj/bjc/6600313 www.bjcancer.com © 2002 Cancer Research UK
Autores principales: | Blower, P, Aapro, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746584/ https://www.ncbi.nlm.nih.gov/pubmed/12085221 http://dx.doi.org/10.1038/sj.bjc.6600313 |
Ejemplares similares
-
Reply: Granisetron vs ondansetron: is it a question of duration of 5-HT(3) receptor blockade?
por: de Wit, R, et al.
Publicado: (2002) -
Granisetron versus Ondansetron: Comparison of 5HT(3) antagonists in preventing spinal anaesthesia induced hemodynamic instability in obstetric patients
por: Wahid, Maheen, et al.
Publicado: (2022) -
Response: Comparative electrocardiographic effects of intravenous ondansetron and granisetron in patients undergoing surgery for carcinoma breast: A prospective single blind randomised trial
por: Ganjare, Ashish, et al.
Publicado: (2013) -
Postoperative pharmacodynamic interaction of ondansetron; a 5-HT3 antagonist and paracetamol in patients operated in the ENT department under local anesthesia
por: Bhosale, Uma A., et al.
Publicado: (2014) -
Postoperative nausea and vomiting prophylaxis: A comparative study of ondansetron, granisetron and granisetron and dexamethasone combination after modified radical mastectomy
por: Gupta, Pushplata, et al.
Publicado: (2014)